10. Long-term treatment for ACS (English Version)

How can you formulate a long-term plan for an ACS patient before hospital discharge & during follow-up at the OPD?
0:00 Intro
1:52 Cardiac Rehabilitation
3:28 Lifestyle Management
9:44 Pharmacotherapy
22:28 Adherence & Persistence
27:16 Imaging
28:06 Vaccination
28:56 Patient Perspectives
32:03 Finale
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
www.escardio.o...
2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data
oup.silverchai...
2021 ESC Guidelines of CVD Prevention
www.escardio.o...
Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (Arabic Version)
• Preamble to CVD Preven...
Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (English Version)
• Preamble to CVD Preven...
2019 ESC Guidelines of Management of Chronic Coronary Syndromes
www.escardio.o...
IMPROVE-IT trial. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
www.nejm.org/d...
ODYSSEY OUTCOMES trial. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
www.nejm.org/d...
REMINDER trial. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure
pubmed.ncbi.nl...
EPHESUS trial. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
www.nejm.org/d...
PARADISE-MI trial. Prospective ARNI versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI.
www.acc.org/La...
EMPAREG-OUTCOME trial. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
pubmed.ncbi.nl...
CANVAS trial. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
www.nejm.org/d...
DECLARE-TIMI 58. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
www.nejm.org/d...
EMMY trial. Empagliflozin in acute myocardial infarction.
academic.oup.c...
SECURE trial. Polypill Strategy in Secondary Cardiovascular Prevention
www.nejm.org/d...